Diurnal completes IPO in dark days of December

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Diurnal completes IPO in dark days of December

microscope_230px
Scientific microscope in the laboratory. | Kurhan - Fotolia

Diurnal Group, a UK company developing drugs to treat rare chronic hormonal imbalances, completed its Aim IPO for £25m on Monday, gaining a £75m market cap.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article